Literature DB >> 26989985

New insights into the yin and yang of the endocannabinoid system in health and disease.

Cherry L Wainwright1.   

Abstract

LINKED ARTICLES: This article is part of a themed section on Endocannabinoids. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v173.7/issuetoc.

Mesh：

Substances：

Year:  2016        PMID： 26989985      PMCID： PMC5341336          DOI： 10.1111/bph.13451

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


  16 in total

1.  EFFECTS OF TETRAHYDROCANNABINOLS AND OTHER DRUGS ON OPERANT BEHAVIOR IN RATS.

Authors:  E S BOYD; E D HUTCHINSON; L C GARDNER; D A MERITT
Journal:  Arch Int Pharmacodyn Ther       Date:  1963-08-02

2.  Structure-activity relationship (SAR) and pharmacological peculiarities of new synthetic congeners of tetrahydrocannabinol.

Authors:  S LOEWE; R ADAMS
Journal:  Fed Proc       Date:  1947

3.  New insights into the yin and yang of the endocannabinoid system in health and disease.

Authors:  Cherry L Wainwright
Journal:  Br J Pharmacol       Date:  2016-04       Impact factor: 8.739

Review 4.  Role of the endocannabinoid system in diabetes and diabetic complications.

Authors:  G Gruden; F Barutta; G Kunos; P Pacher
Journal:  Br J Pharmacol       Date:  2015-08-20       Impact factor: 8.739

5.  The endocannabinoid system regulates synaptic transmission in nucleus accumbens by increasing DAGL-α expression following short-term morphine withdrawal.

Authors:  Xing-Qin Wang; Jie Ma; Wei Cui; Wei-Xin Yuan; Gang Zhu; Qian Yang; Li-Jun Heng; Guo-Dong Gao
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

6.  Renal effects of chronic pharmacological manipulation of CB2 receptors in rats with diet-induced obesity.

Authors:  K A Jenkin; L O'Keefe; A C Simcocks; J F Briffa; M L Mathai; A J McAinch; D H Hryciw
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

7.  The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels.

Authors:  Stefania Petrosino; Aniello Schiano Moriello; Santiago Cerrato; Mariella Fusco; Anna Puigdemont; Luciano De Petrocellis; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2015-03-26       Impact factor: 8.739

8.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

Authors:  W A Devane; L Hanus; A Breuer; R G Pertwee; L A Stevenson; G Griffin; D Gibson; A Mandelbaum; A Etinger; R Mechoulam
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

9.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.

Authors:  R Mechoulam; S Ben-Shabat; L Hanus; M Ligumsky; N E Kaminski; A R Schatz; A Gopher; S Almog; B R Martin; D R Compton
Journal:  Biochem Pharmacol       Date:  1995-06-29       Impact factor: 5.858

10.  Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis.

Authors:  Vanessa Deveaux; Thomas Cadoudal; Yasukatsu Ichigotani; Fatima Teixeira-Clerc; Alexandre Louvet; Sylvie Manin; Jeanne Tran-Van Nhieu; Marie Pierre Belot; Andreas Zimmer; Patrick Even; Patrice D Cani; Claude Knauf; Remy Burcelin; Adeline Bertola; Yannick Le Marchand-Brustel; Philippe Gual; Ariane Mallat; Sophie Lotersztajn
Journal:  PLoS One       Date:  2009-06-09       Impact factor: 3.240
View more
  1 in total

1.  New insights into the yin and yang of the endocannabinoid system in health and disease.

Authors:  Cherry L Wainwright
Journal:  Br J Pharmacol       Date:  2016-04       Impact factor: 8.739
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.